International Clinical Trial: Exploratory Clinical Trial on the Efficacy and Safety of Ematinib Tablets in the Treatment of Pediatric Moderate-to-Severe Alopecia Areata

Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121832) titled 'Exploratory Clinical Trial on the Efficacy and Safety of Ematinib Tablets in the Treatment of Pediatric Moderate-to-Severe Alopecia Areata' on April 3.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: The First Affiliated Hospital of Army Medical University

Condition: alopecia areata

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-06

Target Sample Size: Ematinib Treatment Group :55;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=316360

Published by HT Digital Content Services with permissio...